Performance of LMAT LeMaitre Vascular | 83.8% in 12m
Compare LMAT with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare LeMaitre Vascular with its related Sector/Index XLV
Performance Duell LMAT vs XLV
TimeFrame | LMAT | XLV |
---|---|---|
1 Week | 0.46% | -0.25% |
1 Month | 0.98% | -1.71% |
3 Months | 3.91% | 1.61% |
6 Months | 42.9% | 10.92% |
12 Months | 83.8% | 20.88% |
YTD | 59.2% | 11.05% |
Rel. Perf. 1m | 0.33 | |
Rel. Perf. 3m | 0.76 | |
Rel. Perf. 6m | 2.58 | |
Rel. Perf. 12m | 4.45 | |
Spearman 1m | 0.13 | -0.373 |
Spearman 3m | 0.71 | 0.464 |
Is LeMaitre Vascular a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, LeMaitre Vascular (NASDAQ:LMAT) is currently (October 2024)
a good stock to buy. It has a ValueRay Fundamental Rating of 77.66 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LMAT as of October 2024 is 106.44. This means that LMAT is currently undervalued and has a potential upside of +18.68% (Margin of Safety).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LMAT as of October 2024 is 106.44. This means that LMAT is currently undervalued and has a potential upside of +18.68% (Margin of Safety).
Is LMAT a buy, sell or hold?
- Strong Buy: 4
- Buy: 3
- Hold: 2
- Sell: 0
- Strong Sell: 0
Values above 0%: LMAT is performing better - Values below 0%: LMAT is underperforming
Compare LMAT with Broad Market Indices
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -0.62% | -2.76% | 25.77% | 43.69% |
US NASDAQ 100 | QQQ | 0.73% | -2.92% | 27.14% | 44.33% |
US Dow Jones Industrial 30 | DIA | -1.37% | -2.97% | 27.30% | 50.97% |
German DAX 40 | DBXD | -0.52% | -3.36% | 33.81% | 53.93% |
UK FTSE 100 | ISFU | -0.03% | 1.70% | 29.35% | 59.62% |
Shanghai Shenzhen CSI 300 | CSI 300 | 8.89% | -15.95% | 34.51% | 72.48% |
Hongkong Hang Seng | HSI | 5.39% | -8.11% | 19.00% | 72.75% |
Japan Nikkei 225 | EXX7 | 0.91% | -3.17% | 39.63% | 60.85% |
India NIFTY 50 | INDA | 1.79% | 3.78% | 32.31% | 55.72% |
Brasil Bovespa | EWZ | 0.88% | 6.91% | 45.64% | 82.39% |
LMAT LeMaitre Vascular vs. Sectors
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -0.38% | -2.50% | 28.95% | 46.20% |
Consumer Discretionary | XLY | -0.20% | -2.13% | 27.04% | 51.73% |
Consumer Staples | XLP | -0.61% | 2.14% | 29.58% | 58.41% |
Energy | XLE | 2.19% | -3.18% | 44.98% | 79.94% |
Financial | XLF | -3.88% | -4.43% | 21.98% | 33.54% |
Health Care | XLV | 0.71% | 2.69% | 31.93% | 62.94% |
Industrial | XLI | -1.64% | -4.58% | 27.43% | 40.98% |
Materials | XLB | -1.61% | -3.23% | 32.58% | 52.11% |
Real Estate | XLRE | -2.89% | 1.55% | 16.36% | 43.40% |
Technology | XLK | 0.60% | -4.19% | 26.73% | 42.43% |
Utilities | XLU | -3.26% | -2.75% | 13.80% | 38.79% |
Aerospace & Defense | XAR | -3.30% | -6.02% | 19.24% | 40.97% |
Biotech | XBI | -2.74% | 2.60% | 25.38% | 35.20% |
Homebuilder | XHB | -2.90% | -1.18% | 19.14% | 7.24% |
Retail | XRT | -4.00% | -1.77% | 31.41% | 50.01% |
Does LeMaitre Vascular outperform its market, is LMAT a Sector Leader?
Yes, over the last 12 months LeMaitre Vascular (LMAT) made 83.82%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 20.88%.
Over the last 3 months LMAT made 3.91%, while XLV made 1.61%.
Yes, over the last 12 months LeMaitre Vascular (LMAT) made 83.82%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 20.88%.
Over the last 3 months LMAT made 3.91%, while XLV made 1.61%.
Period | LMAT | XLV | S&P 500 |
---|---|---|---|
1 Month | 0.98% | -1.71% | 3.74% |
3 Months | 3.91% | 1.61% | 4.88% |
12 Months | 83.82% | 20.88% | 40.13% |